vs
Side-by-side financial comparison of Hour Loop, Inc (HOUR) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.
SOLENO THERAPEUTICS INC is the larger business by last-quarter revenue ($66.0M vs $56.1M, roughly 1.2× Hour Loop, Inc). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs -1.2%, a 40.6% gap on every dollar of revenue. SOLENO THERAPEUTICS INC produced more free cash flow last quarter ($43.5M vs $3.0M).
Hour Loop, Inc. is an e-commerce retail company that offers a diverse portfolio of products including home goods, apparel, toys, electronics accessories, and daily consumer essentials. It primarily operates through leading third-party online marketplaces, with its core customer base concentrated in North America, focusing on delivering affordable, high-value daily products to mass consumers.
SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.
HOUR vs SLNO — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $56.1M | $66.0M |
| Net Profit | $-657.3K | $26.0M |
| Gross Margin | 49.6% | 98.3% |
| Operating Margin | -1.5% | 33.5% |
| Net Margin | -1.2% | 39.4% |
| Revenue YoY | 3.0% | — |
| Net Profit YoY | 57.0% | 134.0% |
| EPS (diluted) | $-0.02 | $0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.1M | — | ||
| Q3 25 | $33.4M | $66.0M | ||
| Q2 25 | $27.1M | $32.7M | ||
| Q1 25 | $25.8M | — | ||
| Q4 24 | $54.4M | — | ||
| Q3 24 | $31.1M | — | ||
| Q2 24 | $28.1M | — | ||
| Q1 24 | $24.7M | — |
| Q4 25 | $-657.3K | — | ||
| Q3 25 | $530.6K | $26.0M | ||
| Q2 25 | $1.2M | $-4.7M | ||
| Q1 25 | $654.5K | — | ||
| Q4 24 | $-1.5M | — | ||
| Q3 24 | $469.6K | — | ||
| Q2 24 | $649.1K | — | ||
| Q1 24 | $1.1M | — |
| Q4 25 | 49.6% | — | ||
| Q3 25 | 51.4% | 98.3% | ||
| Q2 25 | 57.2% | 97.9% | ||
| Q1 25 | 54.7% | — | ||
| Q4 24 | 45.7% | — | ||
| Q3 24 | 54.8% | — | ||
| Q2 24 | 55.7% | — | ||
| Q1 24 | 58.6% | — |
| Q4 25 | -1.5% | — | ||
| Q3 25 | 2.2% | 33.5% | ||
| Q2 25 | 6.0% | -20.0% | ||
| Q1 25 | 3.6% | — | ||
| Q4 24 | -4.5% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 6.2% | — |
| Q4 25 | -1.2% | — | ||
| Q3 25 | 1.6% | 39.4% | ||
| Q2 25 | 4.3% | -14.4% | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 4.3% | — |
| Q4 25 | $-0.02 | — | ||
| Q3 25 | $0.01 | $0.47 | ||
| Q2 25 | $0.04 | $-0.09 | ||
| Q1 25 | $0.02 | — | ||
| Q4 24 | $-0.04 | — | ||
| Q3 24 | $0.01 | — | ||
| Q2 24 | $0.02 | — | ||
| Q1 24 | $0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $498.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.0M | $494.8M |
| Total Assets | $23.8M | $599.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $498.9M | ||
| Q2 25 | — | $286.8M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.9M | — |
| Q4 25 | $7.0M | — | ||
| Q3 25 | $7.7M | $494.8M | ||
| Q2 25 | $7.2M | $240.1M | ||
| Q1 25 | $5.8M | — | ||
| Q4 24 | $5.2M | — | ||
| Q3 24 | $6.7M | — | ||
| Q2 24 | $6.2M | — | ||
| Q1 24 | $5.5M | — |
| Q4 25 | $23.8M | — | ||
| Q3 25 | $31.6M | $599.9M | ||
| Q2 25 | $23.0M | $332.3M | ||
| Q1 25 | $19.1M | — | ||
| Q4 24 | $20.0M | — | ||
| Q3 24 | $32.4M | — | ||
| Q2 24 | $20.2M | — | ||
| Q1 24 | $16.7M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $43.5M |
| Free Cash FlowOCF − Capex | $3.0M | $43.5M |
| FCF MarginFCF / Revenue | 5.3% | 65.8% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | $2.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | — | ||
| Q3 25 | $500.4K | $43.5M | ||
| Q2 25 | $-901.5K | $-12.6M | ||
| Q1 25 | $-23.9K | — | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $-2.2M | — | ||
| Q2 24 | $456.2K | — | ||
| Q1 24 | $492.9K | — |
| Q4 25 | $3.0M | — | ||
| Q3 25 | $449.3K | $43.5M | ||
| Q2 25 | $-901.6K | $-12.6M | ||
| Q1 25 | $-24.6K | — | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $-2.2M | — | ||
| Q2 24 | $439.4K | — | ||
| Q1 24 | $475.1K | — |
| Q4 25 | 5.3% | — | ||
| Q3 25 | 1.3% | 65.8% | ||
| Q2 25 | -3.3% | -38.6% | ||
| Q1 25 | -0.1% | — | ||
| Q4 24 | 2.8% | — | ||
| Q3 24 | -7.0% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 1.9% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.94× | 1.67× | ||
| Q2 25 | -0.77× | — | ||
| Q1 25 | -0.04× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -4.64× | — | ||
| Q2 24 | 0.70× | — | ||
| Q1 24 | 0.46× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
